David P. Meeker

David P. Meeker is a declared insider at 3 companies; the most frequent names are Rhythm Pharmaceuticals, Inc., Trevi Therapeutics, Inc. and MyoKardia, Inc. The record holds 23 filings, for trades running from 10 October 2017 to 14 September 2026.

The open-market side counts 2 purchases for €460k alongside 6 sales for €6.1M. Sales outweigh purchases by €5.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant and 9 option exercises. 2026 to date brings no purchases and 5 sales.

The record was last updated on 14 September 2026 with an option exercise (€261k) in Rhythm Pharmaceuticals, Inc. The last purchase on record was published on 13 May 2019, which is 2,717 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.